Abstract
Beta-cell replacement is an effective treatment for type 1 diabetes, but its applicability is limited by the lack of sufficient donor tissue, raising the need for alternative tissue sources. Deriving β cells from stem cell precursors offers an unlimited renewable source of tissue for transplantation and in recent years has become the focus of research in many laboratories. The unique state of embryonic stem (ES) cells is characterized by continuous proliferation through a cell cycle consisting of an abbreviated G1 phase. Although this cell cycle exposes ES cells to potential mutations, it also allows continuous culture of undifferentiated cells. Current protocols directing the differentiation of ES cells mimic the normal embryonic development of β cells through definitive endoderm, foregut endoderm, pancreatic precursors, and endocrine progenitor cells. At present all of these steps are suboptimal, since only some of the cells follow this pathway to the intended product. Moral concerns surrounding the use of embryonic stem cells has led to development of alternative sources of pluripotent cells. Current advances in cellular reprogramming are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aladjem MI, Spike BT, Rodewald LW et al (1998) ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol 8:145–155
Baetge EE (2008) Production of beta-cells from human embryonic stem cells. Diabetes Obes Metab 10 (Suppl 4):186–194
Becker KA, Stein JL, Lian JB et al (2007) Establishment of histone gene regulation and cell cycle checkpoint control in human embryonic stem cells. J Cell Physiol 210:517–526
Bhushan A, Itoh N, Kato S et al (2001) Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 128:5109–5117
Cheng AM, Saxton TM, Sakai R et al (1998) Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 95:793–803
Cho YM, Lim JM, Yoo DH et al (2008) Betacellulin and nicotinamide sustain PDX1 expression and induce pancreatic beta-cell differentiation in human embryonic stem cells. Biochem Biophys Res Commun 366:129–134
D‘Amour KA, Agulnick AD ,Eliazer S et al (2005) Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23:1534–1541
D‘Amour KA, Bang AG, Eliazer S et al (2006) Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 24:1392–1401
Dannenberg JH, van Rossum RA, Schuijff L et al (2000) Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 14:3051–3064
Deutsch G, Jung J, Zheng M et al (2001) A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 128:871–881
Docherty K, Bernardo AS, Vallier L (2007) Embryonic stem cell therapy for diabetes mellitus. Semin Cell Dev Biol 18:827–838
Efrat S (2008) Beta-cell replacement for insulin-dependent diabetes mellitus. Adv Drug Deliv Rev 60:114–123
Eshpeter A, Jiang J, Au M et al (2008) In vivo characterization of transplanted human embryonic stem cell-derived pancreatic endocrine islet cells. Cell Prolif 41:843–858
Fortunel NO, Out HH, Ng HH et al (2003) Comment on “ ‘Stemness’: transcriptional profiling of embryonic and adult stem cells” and “a stem cell molecular signature.” Science 302:393
Francini F, Del ZH, Massa ML et al (2009) Selective effect of INGAP-PP upon mouse embryonic stem cell differentiation toward islet cells. Regul Pept 153:43–48
Frandsen U, Porneki AD, Floridon C et al (2007) Activin B mediated induction of Pdx1 in human embryonic stem cell derived embryoid bodies. Biochem Biophys Res Commun 362:568–574
Gadue P, Huber TL, Paddison PJ et al (2006) Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc Natl Acad Sci USA 103:16806–16811
Gouon-Evans V, Boussemart L, Gadue P et al (2006) BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 24:1402–1411
Gritsman K, Talbot WS, Schier AF (2000) Nodal signaling patterns the organizer. Development 127:921–932
Hallmann D, Trumper K, Trusheim H et al (2003) Altered signaling and cell cycle regulation in embryonal stem cells with a disruption of the gene for phosphoinositide 3-kinase regulatory subunit p85alpha. J Biol Chem 278:5099–5108
Hardikar AA, Lees JG, Sidhu KS et al (2006) Stem-cell therapy for diabetes cure: how close are we? Curr Stem Cell Res Ther 1:425–436
Ivanova NB, Dimos JT, Schaniel C et al (2002) A stem cell molecular signature. Science 298:601–604
Jensen J (2007) Pathway decision-making strategies for generating pancreatic beta-cells: systems biology or hit and miss? Curr Opin Endocrinol Diabetes Obes 14:277–282
Jiang J, Au M, Lu K et al (2007a) Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25:1940–1953
Jiang W, Shi Y, Zhao D et al (2007b) In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res 17:333–344
Jiang W, Bai Z, Zhang D et al (2008) Differentiation of mouse nuclear transfer embryonic stem cells into functional pancreatic beta cells. Diabetologia 51:1671–1679
Jirmanova L, Afanassieff M, Gobert-Gosse S et al (2002) Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 21:5515–5528
Johansson KA, Dursun U, Jordan N et al (2007) Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Dev Cell 12:457–465
Jorgensen MC, Ahnfelt-Ronne J, Hald J et al (2007) An illustrated review of early pancreas development in the mouse. Endocr Rev 28:685–705
Krishna KA, Rao GV, Rao KS (2007) Stem cell-based therapy for the treatment of Type 1 diabetes mellitus. Regen Med 2:171–177
Kroon E, Martinson LA, Kadoya K et al (2008) Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26:443–452
Ku HT, Chai J, Kim YJ et al (2007) Insulin-expressing colonies developed from murine embryonic stem cell-derived progenitors. Diabetes 56:921–929
Kubo A, Shinozaki K, Shannon JM et al (2004) Development of definitive endoderm from embryonic stem cells in culture. Development 131:1651–1662
Lander AD (2007) Morpheus unbound: reimagining the morphogen gradient. Cell 128:245–256
Ludwig TE, Levenstein ME, Jones JM et al (2006) Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24:185–187
McLean AB, D‘Amour KA, Jones KL et al (2007) Activin A efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells 25:29–38
Muller FJ, Laurent LC, Kostka D et al (2008) Regulatory networks define phenotypic classes of human stem cell lines. Nature 455:401–405
Murry CE, Keller G (2008) Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132:661–680
Neganova I, Zhang X, Atkinson S et al (2009) Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene 28:20–30
Nyeng P, Norgaard GA, Kobberup S et al (2007) FGF10 signaling controls stomach morphogenesis. Dev Biol 303:295–310
Prost S, Bellamy CO, Clarke AR et al (1998) p53-independent DNA repair and cell cycle arrest in embryonic stem cells. FEBS Lett 425:499–504
Ramalho-Santos M, Yoon S, Matsuzaki Y et al 2002. “Stemness”: transcriptional profiling of embryonic and adult stem cells. Science 298:597–600
Sage J, Mulligan GJ, Attardi LD et al (2000) Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 14:3037–3050
Sekine K, Ohuchi H, Fujiwara M et al (1999) Fgf10 is essential for limb and lung formation. Nat Genet 21:138–141
Semb H (2008) Definitive endoderm: a key step in coaxing human embryonic stem cells into transplantable beta-cells. Biochem Soc Trans 36:272–275
Sherwood RI, Chen TY, Melton DA (2009) Transcriptional dynamics of endodermal organ formation. Dev Dyn 238:29–42
Shim JH, Kim SE, Woo DH et al (2007) Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. Diabetologia 50:1228–1238
Sordi V, Bertuzzi F, Piemonti L (2008) Diabetes mellitus: an opportunity for therapy with stem cells? Regen Med 3:377–397
Spence JR, Wells JM (2007) Translational embryology: using embryonic principles to generate pancreatic endocrine cells from embryonic stem cells. Dev Dyn 236:3218–3227
Sun H, Lesche R, Li DM et al 1999. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 96:6199–6204
Tada S, Era T, Furusawa C et al (2005) Characterization of mesendoderm: a diverging point of the definitive endoderm and mesoderm in embryonic stem cell differentiation culture. Development 132:4363–4374
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
Thomson JA, Itskovitz-Eldor J, Shapiro SS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
White J, Stead E, Faast R et al (2005) Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation. Mol Biol Cell 16:2018–2027
Xu C, Inokuma MS, Denham J et al (2001) Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19:971–974
Xu C, Rosler E, Jiang J et al (2005) Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells 23:315–323
Yasunaga M, Tada S, Torikai-Nishikawa S et al (2005) Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat Biotechnol 23:1542–1550
Zaret KS (2008) Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation. Nat Rev Genet 9:329–340
Zaret KS, Grompe M (2008) Generation and regeneration of cells of the liver and pancreas. Science 322:1490–1494
Zhang D, Jiang W, Liu M et al (2009) Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res [Epub ahead of print]
Zhou Q, Brown J, Kanarek A et al (2008) In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455:627–632
Acknowledgments
J.J is supported by the Chicago Project, an international effort for a functional cure of diabetes. MAB is a Morgenthaler Fellow, Lerner Research institute, Cleveland Clinic.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bukys, M.A., Jensen, J. (2010). Embryonic Stem Cells as a Potential Cure for Diabetes. In: Efrat, S. (eds) Stem Cell Therapy for Diabetes. Stem Cell Biology and Regenerative Medicine. Humana Press. https://doi.org/10.1007/978-1-60761-366-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-60761-366-4_10
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-365-7
Online ISBN: 978-1-60761-366-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)